X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (9728) 9728
Book Review (1212) 1212
Publication (1061) 1061
Newsletter (633) 633
Conference Proceeding (115) 115
Book Chapter (60) 60
Newspaper Article (36) 36
Dissertation (15) 15
Magazine Article (6) 6
Reference (3) 3
Trade Publication Article (2) 2
Web Resource (2) 2
Data Set (1) 1
Journal / eJournal (1) 1
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
temozolomide (8592) 8592
index medicus (6555) 6555
humans (5754) 5754
oncology (4717) 4717
glioblastoma (3990) 3990
cancer (2894) 2894
female (2888) 2888
male (2853) 2853
chemotherapy (2848) 2848
radiotherapy (2833) 2833
dacarbazine - analogs & derivatives (2471) 2471
middle aged (2330) 2330
glioblastoma multiforme (2290) 2290
adult (2095) 2095
clinical neurology (2094) 2094
aged (1994) 1994
gliomas (1898) 1898
survival (1851) 1851
adjuvant temozolomide (1815) 1815
brain neoplasms - drug therapy (1798) 1798
glioma (1722) 1722
tumors (1678) 1678
brain neoplasms - pathology (1512) 1512
care and treatment (1405) 1405
cell line, tumor (1312) 1312
prognosis (1292) 1292
glioblastoma - drug therapy (1277) 1277
malignant glioma (1275) 1275
animals (1255) 1255
research (1245) 1245
brain tumors (1226) 1226
dacarbazine - therapeutic use (1213) 1213
treatment outcome (1187) 1187
medicine & public health (1176) 1176
apoptosis (1164) 1164
surgery (1134) 1134
glioblastoma - pathology (1127) 1127
analysis (1086) 1086
antineoplastic agents, alkylating - therapeutic use (975) 975
brain cancer (975) 975
brain neoplasms - therapy (963) 963
expression (937) 937
neurology (898) 898
brain neoplasms - mortality (885) 885
brain neoplasms - genetics (836) 836
glioma - drug therapy (798) 798
radiation (795) 795
retrospective studies (794) 794
therapy (793) 793
mice (780) 780
radiation-therapy (774) 774
dacarbazine - administration & dosage (767) 767
radiation therapy (758) 758
health aspects (739) 739
multiforme (733) 733
combined modality therapy (724) 724
newly-diagnosed glioblastoma (718) 718
bevacizumab (716) 716
brain (716) 716
concomitant (714) 714
glioma - pathology (711) 711
dacarbazine - pharmacology (702) 702
glioblastoma - therapy (698) 698
phase-ii (691) 691
glioblastoma - genetics (687) 687
glioblastoma - mortality (679) 679
young adult (677) 677
neurosciences (669) 669
trial (662) 662
aged, 80 and over (651) 651
mgmt (645) 645
phase-ii trial (638) 638
brain neoplasms - radiotherapy (636) 636
patients (624) 624
pharmacology & pharmacy (624) 624
disease-free survival (623) 623
magnetic resonance imaging (617) 617
cell biology (616) 616
medical prognosis (612) 612
glioblastoma-multiforme (608) 608
brain neoplasms - metabolism (598) 598
antineoplastic agents - therapeutic use (589) 589
malignant gliomas (586) 586
antineoplastic combined chemotherapy protocols - therapeutic use (579) 579
survival analysis (574) 574
drug therapy (572) 572
dna methylation (570) 570
adolescent (569) 569
radiology, nuclear medicine & medical imaging (551) 551
glioblastoma - metabolism (550) 550
methylation (550) 550
antineoplastic agents (549) 549
cancer therapies (549) 549
article (533) 533
clinical trials (533) 533
development and progression (532) 532
antimitotic agents (526) 526
gene expression (526) 526
brain-tumors (523) 523
survival rate (505) 505
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (10249) 10249
French (92) 92
German (69) 69
Spanish (29) 29
Japanese (16) 16
Chinese (14) 14
Czech (14) 14
Polish (12) 12
Korean (10) 10
Turkish (7) 7
Hungarian (6) 6
Italian (4) 4
Portuguese (3) 3
Russian (2) 2
Slovak (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer gene therapy, ISSN 0929-1903, 02/2019, Volume 26, Issue 7-8, pp. 257 - 257
All animal experiments were approved by the Animal Care and Use Committee (ACUC), Louisiana State University Health Science Center and not The People's... 
Temozolomide
Journal Article
Reference
Brain metastasis-evidence based management, 12/2006
Advances in cancer management have resulted in a significant increase in median survival of number of diseases. Consequently we are seeing more patients living... 
Brain Metastasis, Management, Temozolomide
Journal
The Journal of clinical endocrinology and metabolism, ISSN 0021-972X, 08/2018, Volume 103, Issue 8, pp. 3115 - 3118
Journal Article
PLoS ONE, ISSN 1932-6203, 06/2018, Volume 13, Issue 6, pp. e0199076 - e0199076
We determine an optimal protocol for temozolomide using population variability and dynamic optimization techniques inspired by artificial intelligence. We use... 
BREAST-CANCER | TRIAL | PHARMACOKINETICS | ONCOLOGY | MULTIDISCIPLINARY SCIENCES | PRECISION MEDICINE | MODEL | METRONOMIC CHEMOTHERAPY | CHILDREN | Temozolomide - pharmacokinetics | Artificial Intelligence | Humans | Antineoplastic Agents, Alkylating - pharmacology | Treatment Outcome | Antineoplastic Agents, Alkylating - pharmacokinetics | Antineoplastic Agents, Alkylating - administration & dosage | Temozolomide - pharmacology | Neoplasms - drug therapy | Antineoplastic Agents, Alkylating - therapeutic use | Dose-Response Relationship, Drug | Temozolomide - therapeutic use | Algorithms | Models, Biological | Temozolomide - administration & dosage | Neoplasms - pathology | Monte Carlo Method | Technology application | Usage | Temozolomide | Pharmacokinetics | Artificial intelligence | Testing | Physiological effects | Operations research | Toxicity | Brain cancer | Variability | Clinical trials | Oncology | Metastasis | Cancer therapies | Optimization | Confidence intervals | Population | Myelosuppression | Drug dosages | Monte Carlo method | Pharmacodynamics | Computer simulation | Search algorithms | Neutrophils | Periodicity | Pharmacology | Breast cancer | FDA approval | Periodic variations | Patients | Chemotherapy | Neural networks | Tumors | Index Medicus | Economies and finances | Humanities and Social Sciences
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2012, Volume 13, Issue 9, pp. 916 - 926
Journal Article
CANCER DISCOVERY, ISSN 2159-8274, 04/2019, Volume 9, Issue 4, pp. 469 - 471
In this issue, Maertens and colleagues demonstrate that HDAC3 inhibition potentiates the effects of MAPK pathway inhibitors in melanoma, including... 
ONCOLOGY | TEMOZOLOMIDE | Index Medicus
Journal Article
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 03/2013, Volume 31, Issue 7, pp. 977 - 978
Journal Article
JAMA, ISSN 0098-7484, 12/2017, Volume 318, Issue 23, pp. 2306 - 2316
Journal Article
Biological and Pharmaceutical Bulletin, ISSN 0918-6158, 2018
Temozolomide (TMZ) is currently the first-line drug used for clinical postoperative or non-surgical chemotherapy for glioma, but acquired and intrinsic... 
temozolomide | synergy | formononetin | glioma
Journal Article
Experimental Cell Research, ISSN 0014-4827, 02/2019, Volume 375, Issue 1, pp. 73 - 81
Glioblastoma multiforme (GBM) is the most malignant tumor of the central nervous system, and chemoresistance blunts the effect of temozolomide (TMZ) in the... 
YY1 | Stemness | Temozolomide | miR-7-5p | Glioblastoma
Journal Article
Annals of Oncology, ISSN 0923-7534, 08/2018, Volume 29, Issue 8, pp. 1628 - 1630
Journal Article
International Journal of Cancer, ISSN 0020-7136, 04/2019, Volume 144, Issue 7, pp. 1735 - 1745
Glioblastoma multiforme (GBM) has a poor prognosis with an overall survival of 14–15 months after surgery, radiation and chemotherapy using temozolomide (TMZ).... 
temozolomide | glioblastoma | autophagy | drug resistance | thioridazine | SURVIVAL | ANGIOGENESIS | NEWLY-DIAGNOSED GLIOBLASTOMA | CONNECTIVITY MAP | CELLULAR-DISTRIBUTION | RADIATION | ADJUVANT TEMOZOLOMIDE | TRIAL | ONCOLOGY | RESISTANCE | TUMOR-GROWTH | Lysosomes - drug effects | Cell Survival - drug effects | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Brain Neoplasms - genetics | Thioridazine - administration & dosage | Synthetic Lethal Mutations | Brain Neoplasms - drug therapy | Autophagy - drug effects | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Drug Synergism | Temozolomide - therapeutic use | Xenograft Model Antitumor Assays | Autophagosomes - drug effects | Animals | Glioblastoma - genetics | Temozolomide - administration & dosage | Thioridazine - pharmacology | Cell Line, Tumor | Cell Proliferation - drug effects | Mice | Glioblastoma - drug therapy | Drug Resistance, Neoplasm - drug effects | RNA | Genes | Brain tumors | Genomics | Drug resistance | Antineoplastic agents | Gene expression | Glioblastoma multiforme | Antimitotic agents | Chemotherapy | Analysis | Health aspects | Phenothiazine | Cancer | Brain | Neuroleptics | Toxicity | Brain cancer | Glioblastoma | Radiation | Phagosomes | Lysosomes | Genomes | Lethality | Drug development | Autophagy | Psychotropic drugs | Surgery | Biocompatibility | RNA-mediated interference | Feasibility studies | Pharmacology | Sensitivity | Thioridazine | Ribonucleic acids | Neural networks | Medical prognosis | Glioblastoma cells | Temozolomide | Phagocytosis | Tumors | Index Medicus
Journal Article
Journal of Cellular Biochemistry, ISSN 0730-2312, 07/2017, Volume 118, Issue 7, pp. 1889 - 1899
In the present study, we have demonstrated that CASC2 plays an important role in the chemo‐resistance of glioma by functioning as a ceRNA to regulate the... 
PTEN | CASC2 | TEMOZOLOMIDE (TMZ) | miR‐181a | GLIOMA | CHEMO‐RESISTANCE | miR-181a | CHEMO-RESISTANCE | BIOCHEMISTRY & MOLECULAR BIOLOGY | ACQUIRED-RESISTANCE | CERVICAL-CANCER | GASTRIC-CANCER CELLS | MESENCHYMAL TRANSITION | CELL BIOLOGY | LONG NONCODING RNA | SIGNALING PATHWAY | COLORECTAL-CANCER | TEMOZOLOMIDE TMZ | TARGETING PTEN | KIDNEY CANCER | Multivariate Analysis | Dacarbazine - therapeutic use | Humans | Middle Aged | Male | MicroRNAs - metabolism | Glioma - metabolism | Dacarbazine - pharmacology | Tumor Suppressor Proteins - genetics | Dacarbazine - analogs & derivatives | Adult | Female | Real-Time Polymerase Chain Reaction | PTEN Phosphohydrolase - genetics | Cell Proliferation - genetics | Tumor Suppressor Proteins - metabolism | Proportional Hazards Models | PTEN Phosphohydrolase - metabolism | RNA, Long Noncoding - genetics | Blotting, Western | Cell Line, Tumor | Protein Binding | Cell Proliferation - drug effects | MicroRNAs - genetics | In Vitro Techniques | RNA, Long Noncoding - metabolism | Glioma - drug therapy | Cell proliferation | Biotechnology | Cell survival | Brain tumors | Chemoresistance | AKT protein | Biochemistry | Biology | Tissues | Survival | Amplification | Sensitivity | Chemotherapy | Coding | Glioma cells | Cell lines | Regulatory mechanisms (biology) | Strategy | Tumorigenesis | Diagnosis | Inhibition | Temozolomide | PTEN protein | Cancer | Index Medicus
Journal Article
Cancer Letters, ISSN 0304-3835, 06/2018, Volume 423, pp. 16 - 26
Chemotherapy is an important treatment for malignant tumors; however, its efficacy and clinical application are limited by its side effects and drug resistance... 
Photothermal therapy | Indocyanine green | Photodynamic therapy | Temozolomide | Melanoma | INDOCYANINE-GREEN | GENE DELIVERY | PHOTODYNAMIC TUMOR-THERAPY | DRUG-DELIVERY | CANCER-THERAPY | CHEMOTHERAPY | BREAST-CANCER | LUNG-CANCER | NANOPARTICLES | ONCOLOGY | IN-VIVO | Melanoma - metabolism | Cell Survival - drug effects | Polyamines - chemistry | Humans | Indocyanine Green | Temozolomide - chemistry | Temozolomide - pharmacology | Drug Delivery Systems | Nanoparticles | Xenograft Model Antitumor Assays | Animals | Temozolomide - administration & dosage | Hyaluronan Receptors - metabolism | Cell Line, Tumor | Cell Proliferation - drug effects | Mice | Hyperthermia, Induced - methods | Melanoma - therapy | Medical colleges | Amines | Active oxygen | Drug resistance | Antineoplastic agents | Photochemotherapy | Antimitotic agents | Chemotherapy | Drug therapy | Hyaluronic acid | Tumors | Cancer | Drugs | Drug delivery systems | Nuclear magnetic resonance--NMR | Toxicity | Fluorescent dyes | Fluorescence | Cytotoxicity | Fluorescent indicators | Anticancer properties | Oxygen production | Temperature effects | CD44 antigen | Conflicts of interest | Infrared radiation | Biocompatibility | Physiology | Oxygen | Light irradiation | I.R. radiation | Light therapy | Phototherapy | Side effects | Singlet oxygen | Irradiation | Index Medicus
Journal Article
The Oncologist, ISSN 1083-7159, 06/2019, Volume 24, Issue 6, pp. 798 - 802
Thymic neuroendocrine tumors are rare malignant tumors of the anterior mediastinum and lack standard treatment options. This report analyzes the efficacy and... 
Thymic atypical carcinoid | Temozolomide | Neuroendocrine tumor | Capecitabine | SURVIVAL | NEUROENDOCRINE TUMORS | CAPECITABINE/TEMOZOLOMIDE | ONCOLOGY | CLASSIFICATION | SINGLE-CENTER
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.